Tags |
|
|
Links |
|
|
Top Adding - Understanding Large-Scale Commercial Mortgage Financing Part-03
This third and final installment of the mini series regarding large-scale commercial mortgage financing will generally discuss how to select a commercial mortgage broker or banker, issues you can expect to deal wit
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
h and how to protect yourself in the process. If you have not read part 01 and 02 of this series, you should do so now.
As mentioned, the commercial mortgage brokerage business is not well regulated and there ar
As mentioned, the commercial mortgage brokerage business is not well regulated and there ar
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
many unscrupulous and crooked operators in the market—shysters who will require up-front fees before you get a loan. And depending on the amount of financing you are seeking, these fees can be substantial, typical
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ly one percent (1%) of the loan amount. In reality, there is no value in paying a commercial mortgage “broker” any up-front fees to get a commercial mortgage for a grade-A income producing property. Why? Typical
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
y, commercial mortgage brokers do not provide financing directly to the borrower. Instead, they tend to represent mortgage “banking firms”, a much more qualified and professional level of operation, who represent
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ife insurance companies in the market. Now, paying fees to mortgage banking firms is a different story because you are dealing with a legal representative of the insurance company providing the financing and applic
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ations fees are normally paid to these banking firms at the appropriate time (generally discussed in part 1-2).
Dishonesty, however, runs in both directions in this business and borrowers can be just as crooked as
Dishonesty, however, runs in both directions in this business and borrowers can be just as crooked as
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
the brokers. For this reason, brokers often demand borrowers to sign non-disclosure/non-circumvention agreements (non-comps) to prevent the borrower from going around the broker directly to the lending organizatio
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
n. This is fair. The mortgage broker has taken time and money to develop conduit relationships with mortgage banking firms which you would not find own your own unless you are already a player with some deals und
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
r your belt.
Before you sign any agreements with a broker, make sure you get legal review, even if you think that you understand the agreement. Many non-comp agreements tend to run in perpetuity and can bind you
Before you sign any agreements with a broker, make sure you get legal review, even if you think that you understand the agreement. Many non-comp agreements tend to run in perpetuity and can bind you
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
or a long, long, time from ever seeking financing own your own without the broker. There are a variety of non-comps floating around and some are better than others. Make sure you have an attorney review them befo
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
re signing. If you do sign a non-comp, makes sure you get a registered list of the broker’s lenders, in writing, so that you are limited only to their current source of lenders. This way you can deal with lenders
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
not on the list directly.
The only time it is reasonable to pay a broker a fee, and I was in the business for quite awhile, is if they are preparing loan request packages for submission to banks (typically busines
The only time it is reasonable to pay a broker a fee, and I was in the business for quite awhile, is if they are preparing loan request packages for submission to banks (typically busines
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
s and/or construction loans). Another occasion to pay fees if the broker is consulting and advising you for the assembly of legal and financial documents needed to facilitate a loan. In this case, there may be som
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
justification for fees and it is a matter of what you are willing to pay. What’s the hourly rate worth? That’s a gut call, around $50.00 hour for every actual billable hour with per-project limits pre-set to say
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
$250.00. When they hit the $250.00 mark, you want to see an audit trail of the billable schedule before authorizing another $250.00 project. Always work in phases to maintain control. What does a bank package c
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ost? For business and construction loans it is not uncommon to pay $1,500 to $5,000.00 or more depending on the size and complexity of the deal. There is a big difference between a $100,000.00 construction loan an
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
a $1,000,000.00 loan.
As with any business relationship in which you find yourself pressed to sign legal documentation it is always a good idea to get legal review first. I have repeated this many times throughou
As with any business relationship in which you find yourself pressed to sign legal documentation it is always a good idea to get legal review first. I have repeated this many times throughou
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
t these articles because many people ignore this advice until they sign a document, and them it is to late.
To your success!
Do you like this tip? You haven’t seen anything yet! Check out our Smart Books Business
To your success!
Do you like this tip? You haven’t seen anything yet! Check out our Smart Books Business
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
products by clicking the link below. We have business kits, books and ebooks to help you get smart-fast. Check us out…. We’ll save you a TON of time and money.
Copyright © 2006 James W. Hart, IV All Rights reserve
Copyright © 2006 James W. Hart, IV All Rights reserve
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.topadding.org.ua/article/138104/topadding-Understanding-LargeScale-Commercial-Mortgage-Financing-Part03.html">Understanding Large-Scale Commercial Mortgage Financing Part-03</a>
BB link (for phorums):
[url=http://www.topadding.org.ua/article/138104/topadding-Understanding-LargeScale-Commercial-Mortgage-Financing-Part03.html]Understanding Large-Scale Commercial Mortgage Financing Part-03[/url]
Related Articles:
How to Boost Web Site Traffic Using Only Proven Free Techniques
Low Rate Home Equity Loan – Tips for Getting the Lowest Rate
Useful Information About Disabilities
Bookmark it:
|